chao liang
Southern University of Science and Technology
Shenzhen, China
Review Editor
Pharmacology of Anti-Cancer Drugs
Editors
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
ling liang
Peking University
Beijing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
shanshan liang
Affiliated Zhongshan Hospital of Dalian University
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
wei liang
Suzhou Municipal Hospital
Suzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
weicheng liang
The Chinese University of Hong Kong
Shatin, China
Review Editor
Pharmacology of Anti-Cancer Drugs
junyi liao
First Affiliated Hospital of Chongqing Medical University
Chongqing, China
Review Editor
Pharmacology of Anti-Cancer Drugs
doyoung lim
Mayo Clinic
Rochester, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
lidia moreira lima
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Review Editor
Pharmacology of Anti-Cancer Drugs
shuhai lin
Xiamen University
Xiamen, China
Review Editor
Pharmacology of Anti-Cancer Drugs
wenzheng lin
Yangzhou University
Yangzhou, China
Review Editor
Pharmacology of Anti-Cancer Drugs
professor michael p lisanti, md-phd, frsa, frsb, frsc
School of Science, Engineering and Environment, University of Salford
Manchester, United Kingdom
Review Editor
Pharmacology of Anti-Cancer Drugs
chun-yu liu
Taipei Veterans General Hospital
Taipei, Taiwan
Review Editor
Pharmacology of Anti-Cancer Drugs
hu liu
Anhui Provincial Cancer Hospital
Hefei, China
Review Editor
Pharmacology of Anti-Cancer Drugs
jing-yuan liu
University of Toledo
Toledo, United States
Review Editor
Pharmacology of Anti-Cancer Drugs
tian liu
Dalian University of Technology
Dalian, China
Review Editor
Pharmacology of Anti-Cancer Drugs
tianqing liu
Western Sydney University
Penrith, Australia
Review Editor
Pharmacology of Anti-Cancer Drugs